Australia’s Symbion Recommends Acceptance Of Primary Acquisition Offer
This article was originally published in PharmAsia News
Australia's health care giant, Symbion Health, now recommends its shareholders accept a $2.4 billion acquisition try by Primary Health Care after the buyer said its bid was unconditional. Primary said in an official notice it now has 53.8 percent of Symbion's voting shares. Primary's offer for more shares is expected to close Feb. 21, when the buyers begin considering whether to divest some of Symbion's assets. (Click here for more
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.